九州通3万药店扩张遭遇“后遗症”，老将出马能刹住车吗？

Core Viewpoint - The rapid expansion of Jiuzhoutong, the largest private pharmaceutical distribution company in China, is facing significant challenges related to compliance and management, raising concerns about its ambitious "ten-thousand store" plan [1][3]. Group 1: Financial Performance - Jiuzhoutong reported a net profit of 10.94 billion yuan for the first half of 2025, a year-on-year decline of 7.33% [8]. - The company recorded a net cash flow from operating activities of -2.317 billion yuan, although this was an improvement of 341 million yuan compared to the previous year [2]. - The overall gross profit margin for the first three quarters was 7.76%, a decrease of 0.2% year-on-year [2]. Group 2: Expansion Strategy - Jiuzhoutong launched the "ten-thousand store franchise" plan in early 2021, aiming to create an integrated online and offline new retail system [4]. - As of the end of the third quarter of 2025, the sales revenue from franchise stores reached 5.402 billion yuan, a year-on-year increase of 43.4% [4]. - The company has expanded its network to over 700 subsidiaries, but this rapid growth has led to management challenges and compliance issues [5][6]. Group 3: Compliance and Management Issues - Jiuzhoutong has faced multiple compliance risks, with 6.96% of its cases involving the company as a defendant, and 45.33% of these cases related to fraud [5][6]. - Several subsidiaries have been blacklisted for providing false information and colluding in bidding processes [5]. - The company's management structure has been criticized for a lack of effective oversight, leading to operational issues at franchise locations [9]. Group 4: Leadership Changes - Jiuzhoutong has undergone significant leadership changes, with veteran executives returning to key management positions after a year [2][14]. - The transition from founder-led management to professional management has resulted in a more aggressive expansion strategy, but it has also led to increased operational risks [12][13]. - The company is currently navigating a transformation phase, with a focus on new retail, new products, and digitalization [12][14].